AbbVie Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from AbbVie Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 20.5 times. Higher than 97% of Healthcare companies in United States.
- Profit Cash Ratio: Over the last 3 years, every $100 of reported profit came with $454 of operating cash. Higher than 94% of Healthcare companies in United States.
- Tangible Assets Ratio: Of every $100 the company owns, $34 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 92% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$454Over the last 3 years, every $100 of reported profit came with $454 of operating cash.
Higher than 94% of Healthcare companies in United States.
Self-Funding Ratio
20.5×Over the last 3 years its own operating cash covered its investment spending (capex) 20.5 times.
Higher than 97% of Healthcare companies in United States.
Cash Locked Ratio
$18For every $100 of sales, $18 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $16 tied up three years earlier.
Less money tied up than 62% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
2/3 · 0/3Sales grew in 2 of the last 3 years; profit grew in 0 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
−$245Sales grew 5% in 3 years, but profit fell: $245 less profit per $100 of extra sales.
Lower than 92% of Healthcare companies in United States.
Asset Productivity Ratio
+5% / -3%In 3 years sales changed by +5% while total assets changed by -3%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
2.2×Debt due within a year is covered 2.2 times by its yearly operating cash.
Higher than 75% of Healthcare companies in United States.
Cash Cushion Ratio
−12%Debt, after subtracting cash, equals 12% of its market value (net debt).
Lower than 80% of Healthcare companies in United States.
Tangible Assets Ratio
34%Of every $100 the company owns, $34 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 92% of Healthcare companies in United States.
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
AbbVie Inc. owes $1.04 for every $1 it owns. Net profit fell 1% in the year to Dec 2025, and shrank 29% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
80.6Investors pay $80.6 for every $1 of AbbVie Inc.'s yearly profit, higher than 88% of Healthcare companies in United States.
P/B ratio
-84.91AbbVie Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$504.0 BThe total market value of all of AbbVie Inc.'s shares at today's price (share price × number of shares), larger than almost all Healthcare companies in United States. PosiCap size class: Tito Cap.
Net worth (book value)
NegativeAbbVie Inc.'s net worth is negative ($5.9 B below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
1.04×AbbVie Inc. owes $1.04 for every $1 it owns, so it owes more than it owns, higher than 88% of Healthcare companies in United States.
Dividend yield
2.43%AbbVie Inc. pays 2.43% of its share price as dividends a year, higher than 83% of dividend-paying Healthcare companies in United States.
Revenue growth
+9%Revenue rose 9% in the year to Dec 2025, and grew 2% a year on average over 3 years.
Profit growth
-1%Net profit fell 1% in the year to Dec 2025, and shrank 29% a year on average over 3 years.
Profit margin
6.9%AbbVie Inc. keeps $7 of every $100 of revenue as net profit.
Cash quality
4.5×Cash from AbbVie Inc.'s business was 4.5× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
6.9×AbbVie Inc.'s operating profit covered its interest costs 6.9 times in the year to Dec 2025.
Cash vs debt
Net debtAbbVie Inc. had $62.2 B more debt than cash (net debt) at Dec 2025.
Questions
What is AbbVie Inc.'s P/E ratio?
Investors pay $80.6 for every $1 of AbbVie Inc.'s yearly profit, higher than 88% of Healthcare companies in United States.
How much does AbbVie Inc. owe compared with what it owns?
AbbVie Inc. owes $1.04 for every $1 it owns, so it owes more than it owns, higher than 88% of Healthcare companies in United States.
Does AbbVie Inc. pay a dividend?
Yes. AbbVie Inc. pays 2.43% of its share price as dividends a year, higher than 83% of dividend-paying Healthcare companies in United States.
Is AbbVie Inc.'s revenue growing?
Revenue rose 9% in the year to Dec 2025, and grew 2% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.